Tacrolimus Induced Diabetes Presenting As Recurrent Pyelonephritis – A Rare Clinical Presentation

Vivek Mohanty, Ravi Kant and Aditya Sudan
Additional contact information
Vivek Mohanty: All India Institute of Medical Sciences Rishikesh, India
Ravi Kant: All India Institute of Medical Sciences Rishikesh, India
Aditya Sudan: All India Institute of Medical Sciences Rishikesh, India

European Journal of Medical and Health Sciences, 2020, vol. 2, issue 4

Abstract: Tacrolimus is immunosuppressive agent used in a variety of skin disorders including vitiligo. Systemic Tacrolimus has been known to cause diabetes by inducing insulin resistance and increasing the activity and expression of glucose transporter , SGLT1 . In addition to this Tacrolimus has direct beta cell toxicity and subsequent insulin secretory defects. Although systemic absorption of tropical Tacrolimus is minimal but cases have been reported where tropical use of Tacrolimus has been associated with the blood levels above therapeutic range causing potential toxicity . Here we highlight a interesting case of a 22 year old female who was on treatment with Tacrolimus ointment for Segmental Vitiligo presented with features of pyelonephritis with past history of similar recurrent episodes and on further investigations was diagnosed to have New Onset Diabetes Mellitus with elevated serum Tacrolimus levels suggesting Tacrolimus induced beta cell dysfunction and insulin resistance thus making it an interesting and rare presentation of potential toxicity.

Keywords: Tacrolimus; Diabetes Mellitus; Pyelonephritis; Vitiligo (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://eu-opensci.org/index.php/ejmed/article/view/40417 Abstract page (text/html)
https://eu-opensci.org/index.php/ejmed/article/download/40417/8967 Full text (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:epw:ejmed0:v:2:y:2020:i:4:id:40417

DOI: 10.24018/ejmed.2020.2.4.417

Access Statistics for this article

More articles in European Journal of Medical and Health Sciences from European Open Science
Bibliographic data for series maintained by Support ().